NEWS
Federal office upholds UW’s stem cell patent
Looking for a print version?
Simply choose ‘Print’ on your computer and a printer-friendly document will be generated.
Also by Nick Penzenstadler:
- Cartoon attacks David Horowitz (May 6, 2008)
- Organization confident 'Sex Toys 101' will go on (May 1, 2008)
- Law School shuts down 'Sex Toys 101' talk (April 30, 2008)
- McCain drives economic line (April 17, 2008)
- McCain stopping in state today (April 16, 2008)
Related Stories:
- Stem cell patents survive challenge (February 29, 2008)
- Stem cells face patent jeopardy (October 4, 2006)
- Supreme Court decision may hurt UW's chances (May 3, 2007)
- Fight to come in patent ruling (April 10, 2007)
- Stem cell patents pass federal test (March 12, 2008)
Share This:
by Nick Penzenstadler
Thursday, February 28, 2008
The University of Wisconsin’s main patent arm’s Wisconsin Alumni Research Foundation announced Thursday morning they were notified of a key trademark decision in their favor.
The United States Patent and Trademark’s Office ruled to uphold the Wisconsin Alumni Research Foundation’s claims in the face of New York and California based biotech organizations that challenged the patent’s validity in 2006.
WARF’s managing director Carl Gulbrandsen said in a statement Thursday the decision coincided with what they had always maintained since 1998.
“We’re extremely pleased with this decision,”
Gulbrandsen said. “It affirms what WARF has believed all along, that Dr.
Thomson’s breakthrough discoveries are patentable inventions.”
The patent, “913,” deals with primate and human embryonic
stem cells. Two other patents, numbers “780” and “806” are still pending a
review by the trademark office.
See more about the future of UW’s stem cell patents in Friday’s edition of The Badger Herald.
Add a comment
We welcome your thoughts, but please keep your feedback thoughtful, on-topic and respectful. Offensive language, personal attacks, or irrelevant comments may be deleted.
Login...
Not registered? Sign up now.
It's quick, free, and the email address you provide will not be sold or solicited.
